Skip to main content
Livermore
Livermore
ZHEN

Evoke Wealth, LLC

SEC CIK
0001793432
Latest filing
Aug 10, 2026

TMO holding history

Thermo Fisher Scientific Inc. in every 13F filed by Evoke Wealth, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

TMO overviewAll 13F holders of TMOFull Q2 2026 holdings

Shares (Q2 2026)
0
Sold out in Q2 2026
Value
$0
% of portfolio
0.0%
Quarters held
19
Since Q1 2021
Holdings of TMO by Evoke Wealth, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20260$00.0%−1,483−100.0%Sold outHolders
Q1 20261,483$729.9K<0.1%−142−8.7%ReducedHolders
Q4 20251,625$942.2K<0.1%−128−7.3%ReducedHolders
Q3 20251,753$851.2K<0.1%+383+28.0%AddedHolders
Q2 20251,370$555.9K<0.1%−96−6.5%ReducedHolders
Q1 20251,466$730.2K<0.1%+287+24.3%AddedHolders
Q4 20241,179$614.0K<0.1%−41−3.4%ReducedHolders
Q3 20241,220$755.4K<0.1%+1,220NewHolders
Q2 20240$00.0%−1,157−100.0%Sold outHolders
Q1 20241,157$673.1K<0.1%+1,157NewHolders
Q4 20230$00.0%−1,116−100.0%Sold outHolders
Q3 20231,116$565.4K<0.1%+177+18.8%AddedHolders
Q2 2023939$490.3K<0.1%+215+29.7%AddedHolders
Q1 2023724$417.6K<0.1%−74−9.3%ReducedHolders
Q4 2022798$439.8K<0.1%−276−25.7%ReducedHolders
Q3 20221,074$545.0K<0.1%−123−10.3%ReducedHolders
Q2 20221,197$651.0K<0.1%−563−32.0%ReducedHolders
Q1 20221,760$1.04M<0.1%+203+13.0%AddedHolders
Q4 20211,557$1.04M<0.1%+27+1.8%AddedHolders
Q3 20211,530$874.0K<0.1%−90−5.6%ReducedHolders
Q2 20211,620$818.0K<0.1%+216+15.4%AddedHolders
Q1 20211,404$641.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.